An important achievement was achieved, concerning the publication of an article in the prestigious international journal “Cancers” entitled “MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment” regarding the centrality of the MYCN oncogene in the pathological context of neuroblastoma. Specifically, the study highlights how MYCN affects High Risk Neuroblastoma cases, in terms of prognosis and therapy; and what are the best strategies to inhibit it.
article link
https://pubmed.ncbi.nlm.nih.gov/36139583/
Download the article
Bartolucci et al. 2022 cancers.
